The bill amends Chapter 5-37.8 of the General Laws, known as the "Protections for Healthcare Providers Act," by adding a new section that establishes prescriptive protections for providers involved in legally protected healthcare activities. Specifically, it allows for the prescription label of medication abortion prescription drugs to include the name of the prescriber's healthcare practice instead of the name of the prescriber, thereby enhancing privacy and protection for healthcare providers.

The bill defines "medication abortion prescription drugs" as substances used in the course of medical treatment intended to induce the termination of a pregnancy, including, but not limited to, mifepristone and misoprostol. This act is set to take effect immediately upon passage.